[July 20, 2017]

Cervical Cancer Disease Coverage Forecast and Market Analysis to 2023 - Research and Markets

The "Cervical Cancer Disease Coverage Forecast and Market Analysis to 2023" report has been added to Research and Markets' offering.

Cervical cancer is a major gynecological cancer which involves uncontrolled cell division and tissue invasiveness of the female uterine cervix. Incidence rates are highest in sub-Saharan Africa, Latin America and the Caribbean, and Oceania/Australasia, and lowest in Western Asia, Australia/New Zealand, and Northern America.

Human papillomavirus (HPV) is a major cause of the main types of cervical cncer (the two main histological subtypes being squamous cell cancer and adenocarcinoma), and is believed to be responsible for around 95% of cervical cancers.

Key Topics Covered:

1. Executive Summary
2. Disease Background
3. Sources and Methodology
4. Forecast
5. Epidemiologist Insight
6. Strengths and Limitations

Companies Mentioned

• AstraZeneca
• Bristol-Myers Squibb
• Celgene
• Genentech
• GlaxoSmithKline
• Merck KGaA
• Pfizer
• Roche

For more information about this report visit https://www.researchandmarkets.com/research/ht4f6g/cervical_cancer

View source version on businesswire.com: http://www.businesswire.com/news/home/20170720005759/en/

[ Back To TMCnet.com's Homepage ]